SABCS 2020: Benefits of Neratinib Over Lapatinib for Breast Cancer Appear Independent of Baseline Central Nervous System Metastases
Findings suggest role for neratinib regardless of the presence of central nervous system metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.